TMO

2025Q3BMO

Thermo Fisher Scientific Inc primary · HEALTHCARE · DIAGNOSTICS & RESEARCH

Report 2025-10-22 · Fiscal end 2025-09-30 · Features as of 2025-10-21

← Earnings history

Pre-Earnings Data

Expectations & setup

Street

Consensus EPS5.50
Consensus rev—
EPS high—
EPS low—
Dispersion—
Analysts—
EPS rev net 7d—
EPS rev net 30d—
Consensus Δ 7d—
Consensus Δ 30d—

Options

Implied move1.8%
IV front—
P/C full—
P/C front—
Features as of2025-10-21

Run-up

Close—
Ret 5d+6.1%
Ret 10d+3.5%
Ret 20d+18.8%
Ret 30d+15.7%

Post-Earnings Data

Results & reaction

Print

Actual EPS
5.79Beat
Estimated EPS5.50
Actual revenue
11.1B
Surprise %+5.3%
Beat / missBeat
Beat streak 44
Beat streak 88

Reaction

1-day stock reaction+2.1%
Implied vs actual

Implied 1.8%Actual 0.4%

Gap reaction-0.4%
Day result+1.7%
Next-day upYes
Realized / IV0.25×

Post tape

Post 5d-1.6%
Post 10d+0.1%
Post volume3.5M
Vol ×10d1.74×
Vol ×20d1.34×
Post range3.7%